Myocardial infarction associated with Chlamydia pneumoniae

Cardiovascular Journal of South Africa

Volumn 11, Issue 1, 2000, Pages 25-28

  Phillips, James I ^a   Shor, Allan ^a,b   Murray, Jill ^b   Ong, Gloria ^c   Taylor Robinson, David ^c  

^a National Centre for Occupational Health   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CASE REPORT; CHLAMYDOPHILA PNEUMONIAE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE;

EID: 0034056904     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Walker ARP. Extremes of coronary heart disease mortality in ethnic groups in Johannesburg, South Africa. Am Heart J 1963; 66: 293-295.
2. Walker ARP, Sareli P. Myocardial infarction in pre-war Leeds. Lancet 1996; 347: 1552-1553.
3. Shor A, Kuo C-C, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82: 158-161.
4. Kuo C-C, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 176: 481-489.
5. Taylor-Robinson D, Thomas BJ. Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol 1998; 51:793-797.
6. Ramirez JA and the Chlamydia pneumoniae/Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996; 125: 979-982.
7. Jackson LA, Campbell LA, Kuo C-C, et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997; 176: 292-295.
8. Maass M, Bartels C, Engel PM, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998; 31: 827-832.
9. Jackson LA, Campbell LA, Schmidt RA, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. Am J Pathol 1997; 150: 1785-1790.
10. Ong G, Thomas BJ, Mansfield AO, et al. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102-106.
11. Shor A, Phillips JI, Ong G, et al. Chlamydia pneumoniae in atheroma: Consideration of criteria for causality. J Clin Pathol 1998; 51: 812-817.
12. Phillips JI, Isaacson C, Carman H. Ochronosis in Black South Africans who used skin lighteners. Am J Dermatopathol 1986; 8: 14-21.
13. Phillips JI. Lack of cilia and squamous metaplasia in upper respiratory tract biopsies from children. S Afr Med J 1989; 76: 355-357.
14. Trehame JD, Darougar S, Jones BR. Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J Clin Pathol 1977; 30: 510-517.
15. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992; 15: 757-763.
16. Bartie C, Klugman KP. Exposure to Legionella pneumophila and Chlamydia pneumoniae in South African mine workers. Int J Occup Med Environ Health 1997; 3: 120-127.
17. Seedat YK, Seedat MA, Nkomo MM. The prevalence of hypertension in the urban Zulu. S Afr Med J 1978; 53: 923-927.
18. Wesslen L, Pahlson C, Primam G, et al. Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer. Lancet 1992; 340: 427-428.
19. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633-636.
20. Gurfinkel E, Bozovich G, Daroca A, et al. and the ROXIS Study Group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404-407.
21. Gupta S, Leathan EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997; 350: 404-407.
22. Thorn DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb Vase Biol 1991; 11: 547-551.
23. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-985.